Document is current
Any future updates will be listed below
-
Authors
Ghahari, Nima https://orcid.org/0000-0002-2370-3046
Caffery, Liam https://orcid.org/0000-0003-1899-7534
Betz-Stablein, Brigid https://orcid.org/0000-0003-3876-501X
Mothershaw, Adam https://orcid.org/0000-0002-0056-8187
Jayasinghe, Dilki https://orcid.org/0000-0003-1467-7664
Primiero, Clare https://orcid.org/0000-0002-2944-0013
Chandra, Shekhar S. https://orcid.org/0000-0001-6544-900X
Torrano, Joachim https://orcid.org/0000-0002-2043-5621
Soyer, H. Peter https://orcid.org/0000-0002-4770-561X
Janda, Monika https://orcid.org/0000-0002-1728-8085
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1137127, APP2006551, APP2006551, APP2006551, APP1137127, APP2006551, APP1137127, APP1137127, APP1137127, APP2006551, APP1137127, APP2006551, APP1137127, APP2006551, APP1137127, APP2006551, APP1137127, APP2006551)
- License Information
-
More Information
Article History
Received: 24 March 2025
Accepted: 20 August 2025
First Online: 30 September 2025
Competing interests
: H.P.S is shareholder of e-derm consult GmbH and MoleMap by Dermatologists Pty Ltd. He provides teledermatological reports regularly for both companies. H.P.S also consults for Canfield Scientific Inc and is an adviser of First Derm.
